Nascent Biotech, Inc. filed its 10-K on Jun 15, 2022 for the period ending Mar 31, 2022. In this report its auditor, Fruci & Associates II, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0764 USD | -21.10% | -22.73% | -55.75% |
1st Jan change | Capi. | |
---|---|---|
-55.75% | 16.53M | |
+18.93% | 125B | |
+14.51% | 108B | |
-4.63% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-12.57% | 16.5B | |
+2.67% | 13.39B | |
+28.56% | 11.1B |
- Stock Market
- Equities
- NBIO Stock
- News Nascent Biotech, Inc.
- Nascent Biotech, Inc. Auditor Raises 'Going Concern' Doubt